115 related articles for article (PubMed ID: 1780327)
21. Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies.
O'Keefe SJ; Haymond MW; Bennet WM; Oswald B; Nelson DK; Shorter RG
Gastroenterology; 1994 Aug; 107(2):379-88. PubMed ID: 7518781
[TBL] [Abstract][Full Text] [Related]
22. Somatostatin inhibits Akt phosphorylation and cell cycle entry, but not p42/p44 mitogen-activated protein (MAP) kinase activation in normal and tumoral pancreatic acinar cells.
Charland S; Boucher MJ; Houde M; Rivard N
Endocrinology; 2001 Jan; 142(1):121-8. PubMed ID: 11145574
[TBL] [Abstract][Full Text] [Related]
23. The effect of octreotide acetate on meal-stimulated exocrine secretion in canine pancreatic autografts.
Garvin PJ; Burton FR; Reese JC; Lingle D; Pandya PK; Niehoff ML
Transplantation; 1991 Sep; 52(3):453-7. PubMed ID: 1716796
[TBL] [Abstract][Full Text] [Related]
24. The effect of somatostatin analogue octreotide on amylase secretion from mouse pancreatic acini.
Ishiguro H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Sobajima H; Nakae Y; Tanikawa M
Digestion; 1993; 54(4):207-12. PubMed ID: 7694882
[TBL] [Abstract][Full Text] [Related]
25. Postprandial exocrine pancreatic function during long-term treatment with the somatostatin analogue SMS 201-995 in acromegalic patients.
Van Liessum PA; Hopman WP; Pieters GF; Smals AG; Tangerman A; Jansen JB; Rosenbusch G; Lamers CB
Eur J Clin Invest; 1990 Aug; 20(4):348-53. PubMed ID: 2121494
[TBL] [Abstract][Full Text] [Related]
26. Effects of SMS 201-995 on basal and stimulated pancreatic secretion in rats.
Guan D; Maouyo D; Sarfati P; Morisset J
Endocrinology; 1990 Jul; 127(1):298-304. PubMed ID: 2361474
[TBL] [Abstract][Full Text] [Related]
27. Barrel rotation in rats induced by SMS 201-995: suppression by ceruletide.
Ishikawa Y; Shimatsu A; Murakami Y; Imura H
Pharmacol Biochem Behav; 1990 Nov; 37(3):523-6. PubMed ID: 2087492
[TBL] [Abstract][Full Text] [Related]
28. Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.
Lembcke B; Creutzfeldt W; Schleser S; Ebert R; Shaw C; Koop I
Digestion; 1987; 36(2):108-24. PubMed ID: 2883060
[TBL] [Abstract][Full Text] [Related]
29. Proliferative response of different exocrine pancreatic cell types to hormonal stimuli. I. Effects of long-term cerulein administration.
Gasslander T; Smeds S; Blomqvist L; Ihse I
Scand J Gastroenterol; 1990 Nov; 25(11):1103-10. PubMed ID: 1703318
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cells.
Colas B; Cambillau C; Buscail L; Zeggari M; Esteve JP; Lautre V; Thomas F; Vaysse N; Susini C
Eur J Biochem; 1992 Aug; 207(3):1017-24. PubMed ID: 1499547
[TBL] [Abstract][Full Text] [Related]
31. Effect of somatostatin 14 on pure human pancreatic secretion.
Gullo L; Priori P; Scarpignato C; Baldoni F; Mattioli G; Barbara L
Dig Dis Sci; 1987 Oct; 32(10):1065-70. PubMed ID: 2888607
[TBL] [Abstract][Full Text] [Related]
32. Effect of cerulein hyperstimulation on the paracellular barrier of rat exocrine pancreas.
Fallon MB; Gorelick FS; Anderson JM; Mennone A; Saluja A; Steer ML
Gastroenterology; 1995 Jun; 108(6):1863-72. PubMed ID: 7539388
[TBL] [Abstract][Full Text] [Related]
33. Octreotide decreases biliary and pancreatic exocrine function, and induces steatorrhea in healthy subjects.
Nakamura T; Kudoh K; Takebe K; Imamura K; Terada A; Kikuchi H; Yamada N; Arai Y; Tando Y; Machida K
Intern Med; 1994 Oct; 33(10):593-6. PubMed ID: 7827373
[TBL] [Abstract][Full Text] [Related]
34. In vivo octreotide administration acutely reduces exocrine granule size in the human pancreas.
Falconi M; Caldiron E; Zancanaro C; Benati D; Talamini G; Bassi C; Pederzoli P
Pancreatology; 2001; 1(1):30-5. PubMed ID: 12120265
[TBL] [Abstract][Full Text] [Related]
35. [Absence of effect of atropine on exocrine pancreatic secretion stimulated by cerulein].
Vázquez Echarri J; Medrano Heredia J; Singer MV
Rev Esp Enferm Dig; 1990 Jun; 77(6):425-31. PubMed ID: 2223251
[TBL] [Abstract][Full Text] [Related]
36. In vitro inhibitory effect of somatostatin on secretin action in exocrine pancreas of rats.
Matsushita K; Okabayashi Y; Hasegawa H; Koide M; Kido Y; Okutani T; Sugimoto Y; Kasuga M
Gastroenterology; 1993 Apr; 104(4):1146-52. PubMed ID: 7681794
[TBL] [Abstract][Full Text] [Related]
37. Circulating somatostatin. Physiological regulator of pancreatic function?
Gyr K; Beglinger C; Köhler E; Trautzl U; Keller U; Bloom SR
J Clin Invest; 1987 Jun; 79(6):1595-600. PubMed ID: 2884233
[TBL] [Abstract][Full Text] [Related]
38. Fluctuations in the secretion of pancreatic enzymes between consecutive doses of octreotide: implications for the management of fistulae.
Jenkins SA; Nott DM; Baxter JN
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):255-8. PubMed ID: 7743308
[TBL] [Abstract][Full Text] [Related]
39. The effect of the long-acting somatostatin analogue octreotide on caerulein-induced pancreatic injuries in rats.
Tulassay Z; Kisfalvi K; Papp M
Z Gastroenterol; 1995 Feb; 33(2):99-102. PubMed ID: 7536997
[TBL] [Abstract][Full Text] [Related]
40. The effect of the somatostatin analogue SMS 201-995 on experimental pancreatic carcinogenesis in the Syrian golden hamster.
Haddock G; Harrison DJ; Carter DC
Carcinogenesis; 1991 Jun; 12(6):1103-7. PubMed ID: 2044191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
